{"entity":{"type":"insider","cik":"0001601692","url":"/insider/0001601692","json_url":"/insider/0001601692.json","name":"KOTLER KEVIN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":125,"n_filings":33,"first":"2014-07-23","last":"2021-11-22","span_basis":"filed_date"},"name_variants":[{"name":"KOTLER KEVIN","source":"filing","n_filings":33,"first_seen":"2014-07-23","last_seen":"2021-11-22"}],"transactions":[{"id":4947470,"accession":"0001103021-21-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000120","line_url":"/filing/0001103021-21-000120#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.06,"price_display":"3.06","price_state":"stated","total_value":306000.0,"total_display":"306,000.00","total_whole":"306,000","shares_owned_after":5158489.0,"shares_owned_after_display":"5,158,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-22","scope":"insider"},{"id":5501569,"accession":"0001103021-21-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000114","line_url":"/filing/0001103021-21-000114#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":5058489.0,"shares_owned_after_display":"5,058,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-15","scope":"insider"},{"id":5247179,"accession":"0001103021-21-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000110","line_url":"/filing/0001103021-21-000110#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":257800.0,"shares_display":"257,800","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":894566.0,"total_display":"894,566.00","total_whole":"894,566","shares_owned_after":4958489.0,"shares_owned_after_display":"4,958,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider"},{"id":4167590,"accession":"0001103021-21-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001103021-21-000046","line_url":"/filing/0001103021-21-000046#line-3","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_display_name":"Broadfin Capital, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":162500.0,"total_display":"162,500.00","total_whole":"162,500","shares_owned_after":4655689.0,"shares_owned_after_display":"4,655,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-13","scope":"insider"},{"id":4167588,"accession":"0001103021-21-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001103021-21-000046","line_url":"/filing/0001103021-21-000046#line-2","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_display_name":"Broadfin Capital, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":324000.0,"total_display":"324,000.00","total_whole":"324,000","shares_owned_after":4605689.0,"shares_owned_after_display":"4,605,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":4167584,"accession":"0001103021-21-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000046","line_url":"/filing/0001103021-21-000046#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_display_name":"Broadfin Capital, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":474000.0,"total_display":"474,000.00","total_whole":"474,000","shares_owned_after":4505689.0,"shares_owned_after_display":"4,505,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":8473395,"accession":"0000919574-19-007768","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-19-007768","line_url":"/filing/0000919574-19-007768#line-4","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":6.32,"price_display":"6.32","price_state":"stated","total_value":6320000.0,"total_display":"6,320,000.00","total_whole":"6,320,000","shares_owned_after":2300066.0,"shares_owned_after_display":"2,300,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-20","scope":"insider"},{"id":8473388,"accession":"0000919574-19-007768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-19-007768","line_url":"/filing/0000919574-19-007768","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":6.485,"price_display":"6.48","price_state":"stated","total_value":6485000.0,"total_display":"6,485,000.00","total_whole":"6,485,000","shares_owned_after":3300066.0,"shares_owned_after_display":"3,300,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider","n_lines":2},{"id":7967885,"accession":"0000919574-19-007363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-19-007363","line_url":"/filing/0000919574-19-007363","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1793757.0,"shares_display":"1,793,757","price_per_share":5.9005568055204805,"price_display":"5.90","price_state":"stated","total_value":10584165.0738,"total_display":"10,584,165.07","total_whole":"10,584,165","shares_owned_after":300066.0,"shares_owned_after_display":"300,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider","n_lines":2},{"id":7967876,"accession":"0000919574-19-007363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-007363","line_url":"/filing/0000919574-19-007363#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2206243.0,"shares_display":"2,206,243","price_per_share":6.037,"price_display":"6.04","price_state":"stated","total_value":13319088.991,"total_display":"13,319,088.99","total_whole":"13,319,089","shares_owned_after":2093823.0,"shares_owned_after_display":"2,093,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-19","scope":"insider"},{"id":7887317,"accession":"0000919574-19-003369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-003369","line_url":"/filing/0000919574-19-003369#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800000.0,"shares_display":"1,800,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":9000000.0,"total_display":"9,000,000.00","total_whole":"9,000,000","shares_owned_after":4281943.0,"shares_owned_after_display":"4,281,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider"},{"id":8697059,"accession":"0000919574-19-002943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-002943","line_url":"/filing/0000919574-19-002943#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":4281943.0,"shares_owned_after_display":"4,281,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-11","filed_date":"2019-04-15","scope":"insider"},{"id":6382569,"accession":"0000919574-18-008175","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":171116.0,"shares_display":"171,116","price_per_share":0.8550185651838519,"price_display":"0.86","price_state":"stated","total_value":146307.3568,"total_display":"146,307.36","total_whole":"146,307","shares_owned_after":1498553.0,"shares_owned_after_display":"1,498,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-27","scope":"insider","n_lines":3},{"id":6382514,"accession":"0000919574-18-008175","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":278485.0,"shares_display":"278,485","price_per_share":0.9146446447744043,"price_display":"0.91","price_state":"stated","total_value":254714.8139,"total_display":"254,714.81","total_whole":"254,715","shares_owned_after":1741359.0,"shares_owned_after_display":"1,741,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider","n_lines":7},{"id":6382494,"accession":"0000919574-18-008175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":392.0,"total_display":"392.00","total_whole":"392","shares_owned_after":1948154.0,"shares_owned_after_display":"1,948,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-24","filed_date":"2018-12-27","scope":"insider"},{"id":6601386,"accession":"0000919574-18-003940","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000919574-18-003940","line_url":"/filing/0000919574-18-003940","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188000.0,"shares_display":"188,000","price_per_share":5.814797872340425,"price_display":"5.81","price_state":"stated","total_value":1093182.0,"total_display":"1,093,182.00","total_whole":"1,093,182","shares_owned_after":2073025.0,"shares_owned_after_display":"2,073,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-24","filed_date":"2018-05-24","scope":"insider","n_lines":5},{"id":6138614,"accession":"0000919574-18-002503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-002503","line_url":"/filing/0000919574-18-002503#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_display_name":"KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":2014000.0,"total_display":"2,014,000.00","total_whole":"2,014,000","shares_owned_after":2236025.0,"shares_owned_after_display":"2,236,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"},{"id":4105443,"accession":"0000919574-17-008727","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-17-008727","line_url":"/filing/0000919574-17-008727","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51000.0,"shares_display":"51,000","price_per_share":9.808627450980392,"price_display":"9.81","price_state":"stated","total_value":500240.0,"total_display":"500,240.00","total_whole":"500,240","shares_owned_after":2436025.0,"shares_owned_after_display":"2,436,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-21","filed_date":"2017-12-22","scope":"insider","n_lines":2},{"id":4105433,"accession":"0000919574-17-008727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-008727","line_url":"/filing/0000919574-17-008727#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":2487025.0,"shares_owned_after_display":"2,487,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-22","scope":"insider"},{"id":4181772,"accession":"0000919574-17-008600","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_display_name":"Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18137.0,"shares_display":"18,137","price_per_share":9.821833820367205,"price_display":"9.82","price_state":"stated","total_value":178138.6,"total_display":"178,138.60","total_whole":"178,139","shares_owned_after":2520262.0,"shares_owned_after_display":"2,520,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-14","scope":"insider","n_lines":2},{"id":4181764,"accession":"0000919574-17-008600","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_display_name":"Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75100.0,"shares_display":"75,100","price_per_share":9.866697736351531,"price_display":"9.87","price_state":"stated","total_value":740989.0,"total_display":"740,989.00","total_whole":"740,989","shares_owned_after":2530162.0,"shares_owned_after_display":"2,530,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider","n_lines":3},{"id":4393144,"accession":"0000919574-17-008511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-008511","line_url":"/filing/0000919574-17-008511#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_display_name":"Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":2605262.0,"shares_owned_after_display":"2,605,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-05","filed_date":"2017-12-07","scope":"insider"},{"id":4299699,"accession":"0000919574-17-008470","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":562428.0,"shares_display":"562,428","price_per_share":5.439540705654768,"price_display":"5.44","price_state":"stated","total_value":3059350.0,"total_display":"3,059,350.00","total_whole":"3,059,350","shares_owned_after":4294426.0,"shares_owned_after_display":"4,294,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider","n_lines":7},{"id":4299678,"accession":"0000919574-17-008470","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-12","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":595000.0,"total_display":"595,000.00","total_whole":"595,000","shares_owned_after":4956854.0,"shares_owned_after_display":"4,956,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-01","scope":"insider"},{"id":4299676,"accession":"0000919574-17-008470","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-11","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":297500.0,"total_display":"297,500.00","total_whole":"297,500","shares_owned_after":4906854.0,"shares_owned_after_display":"4,906,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-01","scope":"insider"},{"id":4299673,"accession":"0000919574-17-008470","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-10","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_display_name":"Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":295000.0,"total_display":"295,000.00","total_whole":"295,000","shares_owned_after":4856854.0,"shares_owned_after_display":"4,856,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-01","scope":"insider"}],"collapsed":true,"next_cursor":"2017-11-30|4299673","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001103021","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","url":"/issuer/0001103021","role":"Director","n_filings":8,"first_seen":"2019-04-15","last_seen":"2021-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000827809","name":"NOVELION THERAPEUTICS INC.","url":"/issuer/0000827809","role":"Ten percent owner","n_filings":1,"first_seen":"2018-12-27","last_seen":"2018-12-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Ten percent owner","n_filings":11,"first_seen":"2014-12-04","last_seen":"2018-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001509190","name":"ARATANA THERAPEUTICS, INC.","url":"/issuer/0001509190","role":"Ten percent owner","n_filings":1,"first_seen":"2017-12-01","last_seen":"2017-12-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-20","last_seen":"2017-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001594337","name":"Corium International, Inc.","url":"/issuer/0001594337","role":"Ten percent owner","n_filings":3,"first_seen":"2017-10-06","last_seen":"2017-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001012477","name":"AVADEL PHARMACEUTICALS PLC","url":"/issuer/0001012477","role":"Ten percent owner","n_filings":1,"first_seen":"2017-06-26","last_seen":"2017-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Ten percent owner","n_filings":3,"first_seen":"2014-07-23","last_seen":"2017-02-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Ten percent owner","n_filings":3,"first_seen":"2015-11-13","last_seen":"2016-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001051514","name":"STRATA Skin Sciences, Inc.","url":"/issuer/0001051514","role":"Ten percent owner","n_filings":1,"first_seen":"2016-03-14","last_seen":"2016-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001601692","retrieved_at":"2026-08-23T09:40:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}